Received: October 26, 2016
Accepted: March 27, 2017
Mediterr J Hematol Infect Dis 2017, 9(1): e2017027 DOI 10.4084/MJHID.2017.027
This article is available on PDF format at:
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background and Objectives:
Migration flux is an increasing phenomenon in Italy, and it raises
several public health issues and concerns in pediatric infectious
diseases. This study investigated the clinical characteristics and
outcomes of a pediatric population at high-risk for tuberculosis (TB)
and the potential role of immigration as a risk factor.
According to the Italian government guidelines, migrants coming from high tuberculosis (TB) endemic countries receive special care for potential Mycobacterium tuberculosis (MT) infection.[1-2] About one-third of the population worldwide encounters MT during their lifespan, remaining asymptomatic, a condition termed latent tuberculosis infection (LTBI).[3,4] However, 5 to 10% of the infected subjects are at risk of developing clinically evident TB, in part depending on their immune system status. In fact, children aged less than 5 years who are co-infected with HIV or treated with immunosuppressants for other diseases are considered at higher risk for TB.[3-5] Among children less than 5 years, those less than 2 years are at even greater risk of severe disseminated TB, including pulmonary miliary TB and meningitis. The diagnosis of LTBI is made when the tuberculosis skin test (TST) is positive in subjects who are not vaccinated and in the absence of any other clinical and/or radiological evidence for active TB. Subjects with LTBI harbor an inactive form of MT. Adequate prophylaxis with isoniazid in LTBI subjects is able to reduce if not eliminate the risk of active disease.[3,4] However, the distinction between latent and active TB may be at times particularly challenging, leading to the concept of a “pediatric TB spectrum” ranging from asymptomatic to lethal TB.[5-7] Children with positive TST but negative chest X-ray (TX) have been recently found to have active TB by microbiological analysis that was confirmed by chest CT scan. As a consequence of this complexity, the “Paediatric Tuberculosis Network European Trials group” has recently proposed to replace LTBI with the new definition of “TB with a positive immunological test result [TST and/or interferon-gamma release assay (IGRA)] in the absence of active disease”, in which the word “latent” is omitted. 
Data recently published by the TB surveillance and monitoring in 29 European States for the year 2012, have shown that 2,845 (4%) out of the total 68,423 cases of TB were found in children. These data show a decrease of 2% compared to the year 2011.
According to the World Health Organization, Italy is one of the countries with a low incidence of TB. However, the progressive reduction of surveillance measures along with the increasing number of immigrants coming from countries at high TB incidence are reasons for the recent alarming reports of a reemerging TB in developed countries.
In Italy, inter-regional differences exist. A recent study on the prevalence of LTBI among 733 healthcare students in Genoa reported a prevalence as low as 1.4%, with migrants coming from a geographical area at high incidence of TB being those most commonly affected. Differently, in Tuscany, the study of a large series of children with TB (n=484), almost half of whom were immigrants, has found no difference between native and immigrant youth. This study has also reported an increase in pediatric TB incidence in Tuscany, where children less than 5 years were at high risk of severe TB.
The proportion of TB affected children in Sardinia, and the impact of the migration flux from TB endemic countries is unknown. Our study is the first report on the clinical characteristics and outcomes of pediatric TB in Northern Sardinia, assessed by TST, IGRA, TX, microbiological culture, direct microscopy for acid-fast bacilli and molecular assays.
Study Population and Methods
For the purpose of this study, any child referred because of household/occasional contact or affected by active TB underwent a personal and family history collection, complete physical examination, TB skin test (TST), interferon-gamma release assay (IGRA) and a thorax X-ray (TX).[10-11] The TST (Biocine Test PPD; Chiron, Siena, Italy) was considered positive when producing a diameter ≥ 5 mm at 48 to 72 hours.
Interferon-gamma release assay (IGRA). The IGRA assay was the quantiFERON Gold in Tube test (QFT). One mL of blood sample was added into three QFT tubes containing either TB antigens ESAT-6, CFP-10 and TB7.7, a positive control (mitogen) or a negative control (Nil). After 16-24 hours incubation at 37°C, plasma IFN-γ concentration was measured by ELISA. QFT results were scored as indicated by the manufacturer (cut-off value for a positive test was ≥0.35 IU/ml).[11-12]
Microbiological diagnosis of tuberculosis. To confirm active TB, standard microbiological culture and molecular genetic assays were performed on patients’ biological samples as previously described.[11-12] Gastric aspirates were collected from children who were TST and/or IGRA positive. Staining and microscopy, nested polymerase chain reaction (PCR) and culture tests were performed as previously described.[11-12] All clinical samples were stained with Zielh-Neelsen and inoculated into liquid and solid medium (MGIT 960 and Lowenstein-Jensen respectively). Molecular tests were carried out using the Dx MTB Assay (Bio-Rad), a Real-time PCR that targets the IS6110 element and the RD9 specific region. DNA was extracted using a chelating ion-exchange resin (InstaGene matrix; Bio-Rad, Hercules, CA) and amplified according to the manufacturer's instructions.
Patient management. Depending on the absence/presence of clinical symptoms, TST/IGRA and TX results, patients were classified into three standard categories of (1) exposed but not infected (asymptomatic, negative to both TST and TX), (2) LTBI (asymptomatic, TST positive but TX negative) and (3) active TB (symptomatic, TX positive or negative, TST positive or negative).
The exposed but not infected children did not receive any treatment but were re-tested for TST and IGRA three months later (Table 1). In accordance with WHO global guidelines, children in this category who were less than 5 years or at risk for developing active TB (e.g,, children in close contact with an index case of TB) received isoniazid at the dosage of 10 mg/kg/day for 3 months before being re-tested (Table 1). Isoniazid was discontinued if both tests were still negative at the second evaluation.
|Table 1. Anti-TB medications and protocols.|
All children who were LTBI received isoniazid prophylaxis for 9 months (Table 1), while all children with active TB underwent a further investigation to confirm the diagnosis. In children with active TB, a DNA fingerprinting assay was performed according to standard protocols.[11-12] Children affected by active TB received the conventional anti-tubercular therapy (Table 1). Treatment for TB lateral-cervical adenopathy was both medical and surgical when indicated. The surgical excision of the affected nodes was used for both diagnostic (microbiological analysis) and therapeutic purposes.
Statistical analysis. Statistical comparisons between groups were performed with the χ2 test or the Fisher’s exact test when indicated. A p-value < 0.05 was considered to be statistically significant.
As shown in Figure 1, about 2/3 (67%) of the immigrants arrived in Sardinia more recently, during the years 2013 and 2014, confirming the reported trend towards a progressive increase in the number of immigrants from countries where TB is endemic, including East Europe and Africa.
|Figure 1. TB high-risk pediatric population observed at the referral Center for pediatric TB in the Northern Sardinia: number of native versus immigrant children stratified per calendar year (2009-2014).|
The study population included 111 (45.1%) children who were less than 5 years old, 117 (47.5%) 5-12 years old, and 18 (7.3%) over 12 years old. In our cohort, the majority of children (n=205; 83.3%) were found to be exposed to TB but not infected, 19 (7.7%) had evidence for LTBI, and 22 children (8.9%) had active TB (Table 2 and Figure 2). As our study involved a high-risk population within institutional settings, a higher prevalence of active TB was found compared to LTBI.
The exposed but not infected group consisted of 145 children (71%) who were not treated and 60 (29%) children who were at risk for developing TB and received isoniazid prophylaxis (Table 2 and Figure 2). Of those children, 53 (25.8%) were native Sardinians, and 7 (3.4%) were immigrants.
Among the 39 children who were TST-positive, 19 (49%) were diagnosed with LTBI because of negative TX and asymptomatic, while 20 (51%) showed active TB (Table 2 and Figure 2). Interestingly, of children who were TST positive, significantly higher proportions were immigrants compared to native Sardinians (42.5% versus 14%, p < 0.001), and there was a trend for immigrant children to have active TB (12.5% vs. 9%, p = 0.050).
|Table 2. Classification of the study population into three categories of “exposed”, “LTBI” and “active TB” patients (n, %), depending on the TST/IGRA and Chest X-ray (TX) negative [–] or positive [+] results at the first evaluation and management.|
|Figure 2. Diagnostic and therapeutic flow-chart of our study population, subdivided into the three categories of latent TB (LTBI), active TB and TB exposed children depending on the TST/IGRA and chest-X Ray (TX) negative [–] or positive [+] results.|
In the LTBI group of 19 children, all but four were TST and IGRA positive. Of these, three (16%; 5, 9 and 11 years old) were TST and IGRA negative, and one (5%; 12 years old) was TST negative but IGRA positive.
Among the 22 children with active TB, 10 (45.4%) children were less than 5 years old, 10 (45.4%) were 5-12 years old, and two (9%) were 14 years old. Half of all TB diagnoses (11/22; 50%) were made in 2009, 5/22 (22%) in 2013, 3/22 (13.6%) in 2010 and 2014 and none in 2011 and 2012. All but three children were TST and IGRA positive. Two of them (9%) tested negative at the first TST and IGRA evaluation (Table 3). One of these was a 9-year old boy under immunosuppressive treatment for juvenile idiopathic arthritis, who underwent TB investigation because of fever and cough. At the initial evaluation, TST and IGRA were negative, but the TX and the culture of gastric aspirate were positives, allowing the diagnosis of active TB (Table 3). Three months later, at the second evaluation, TST and IGRA turned positive. The second patient was a 2-year old girl with a few months history of fever of unknown origin, lack of appetite and irritability. Because of the initial negative laboratory tests, the diagnosis of TB went unrecognized until she presented with the severe clinical picture of disseminated TB, including pulmonary miliary, meningitis, bone and renal involvement (Table 3, Figure 3).
|Table 3. Clinical and radiological findings associated to TST and/or TX positivity at the initial evaluation in the 22 children with active TB.|
|Figure 3. Chest radiograph and brain MRI images of a 2-year-old girl with disseminated TB.|
In the 22 children with active TB, pulmonary involvement with hilar lymphadenopathy was the most common clinical manifestation (n=16 patients, 72%), followed by pleurisy in two patients (13,6%), and one patient each (4.5%) had pleurisy and axillary lymphadenopathy, pneumonia with calcifications, cervical lymphadenopathy, or disseminated TB (miliary and meningitis) (Table 3, Figures 3-5).
|Figure 4. Chest radiographs at two different time points of a 9-year-old girl with pleurisy.|
|Figure 5. Chest TC images of 9-year-old girl with pleurisy at the time of TB diagnosis.|
In one of two patients who presented with adenopathy as extra-pulmonary TB, the initial ultrasound imaging revealed cervical lymphoadenopathy with a concomitant involvement of the parotid gland, which is a known contraindication for surgical treatment (potential risk of causing VII cranial nerve lesion). This patient was a 3-year-old girl in whom the MT etiology was confirmed by culture of the gastric fluid aspirate and by the PCR of the caseous material collected from an external skin fistula that was drained from the colliquative node. The second patient who developed axillary adenopathy as secondary MDR-TB was an 8-year-old boy with Down syndrome, who was initially affected with tubercular pleurisy. According to the conventional therapy protocol, this child received treatment with rifampin, isoniazid, ethambutol and pyrazinamide for 18 months. At the fifth month of follow-up, he presented with axillary lymphoadenopathy. The culture of surgically excised lymphonodal tissue revealed multi-drug resistant MT.[13,14] Anti-TB treatment with amikacin, ethionamide, levofloxacin, and pyrimethamine was successful, with complete recovery after one year of therapy.
Among the children who were symptomatic when they came to the Center, it was possible to identify the index case only in 6 children (50%), while the identification of the TB contact preceded the diagnosis of TB in all the 10 children referred to the Center by the Public Health Service. When known, the index case was an adult in all but one case (a school companion). In the majority (9/16 children), it was one of the parents, mostly the father, followed by an uncle in four cases, a grandparent in one, and a neighbor in another one.
The results of our study showed a strong concordance between TST and IGRA tests, which appears to be not affected by a younger age. The higher percentage of discordant tests was noted among LTBI cases that presented with negative IGRA in spite of a positive TST (3 patients). All this suggests the utility of performing both the tests in all children, as it has been previously reported.
The clinical study revealed that hilar lymphoadenopathy with pneumonia is the most common manifestation of TB in children. These were mostly the children referred because of household or occasional contacts with index cases. On the other hand, children in our study with the most advanced and severe TB manifestations were exclusively those with de novo diagnosis, confirming that contact tracing plays a key role in limiting the consequence of TB in children.
In addition, it important to note that of the children who received isoniazid prophylaxis, none developed active TB. At least one-third of these children were immigrants. Thus, pediatric TB prevention assumes a priority in public health.
• pediatric TB is a public health issue in Northern Sardinia;
• immigrant children have a high rate of LTBI;
• the progressively increasing “boat migration” phenomenon requires immediate action on the TB surveillance level in current low incidence countries;
• TB diagnosis cannot be excluded in children with initial negative TST and IGRA and in whom other diseases have been ruled out by appropriate investigations; a delay in TB diagnosis and treatment is potentially fatal;
• the presence of MDR-TB should always be expected, especially in children living in high-risk families;
• the household or occasional contacts of index cases referred by the local Public Health System significantly benefit from earlier diagnosis and treatment compared to the ex-novo active TB children.
AcknowledgementsWe are grateful to Professor Giovanni Fadda for advice and helpful discussion and to Dr. Mark Soloski and Mary Blue for assistance with writing in the English language. This work was partially supported by the Autonomous Region of Sardinia.
- Italian Ministry of Health. Guidelines for the control of tuberculosis on the proposal of the Minister of Health under Article 115, paragraph 1, letter b of Legislative Decree 31, March 1998, no. 112.
- Bua A, Cubeddu M, Piras D, Delogu R, Zanetti S, Molicotti P. Tuberculosis screening among asylum seekers in Sardinia. J Public Health (Oxf). 2016 Jan 24. pii: fdv215. [Epub ahead of print]
- Abubakar I, Griffiths C, Ormerod P. Diagnosis of active and latent tuberculosis: summary of NICE guidance. BMJ 2012; 345: e6828.
- WHO. Global tuberculosis report 2016. World Health Organization, Geneva; 2016 http://www.who.int/tb/publications/global_report/en/
- Tebruegge M, Salo E, Ritz N, Kampmann B. On Behalf Of The Paediatric Tuberculosis Network European Trialsgroup Ptbnet (2013) Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases. Thorax 68: 588. thoraxjnl-2012-202824. https://doi.org/10.1136/thoraxjnl-2012-202824
- Buonsenso D, Sali M, Focarelli B, Onesimo R, Palucci I, Delogu G, et al. The tuberculosis spectrum: Translating basic research into pediatric clinical practice. Med Hypotheses. 2015 Oct 28. pii: S0306-9877(15)00410-7.
- Sali M, Buonsenso D, Goletti D, D'Alfonso P, Zumbo A, Fadda G, et al. Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children. PLoS One. 2015 Oct 6;10(10):e0138952. doi: 10.1371/journal.pone.0138952. https://doi.org/10.1371/journal.pone.0138952
- Eurosurveillance Editorial Team. ECDC and WHO/Europe joint report on tuberculosis surveillance and monitoring in Europe. Euro Surveill. 20140;19(11). pii: 20741.
- Durando P, Alicino C, Orsi A, Barberis I, Paganino C, Dini G, et al. Latent tuberculosis infection among a large cohort of medical students at a teaching hospital in Italy. Biomed Res Int. 2015;2015:746895. https://doi.org/10.1155/2015/746895 PMid:25705685 PMCid:PMC4331323
- Chiappini E, Bonsignori F, Orlandini E, Sollai S, Venturini E, Galli L, de Martino M. Increasing incidence of tuberculosis in Tuscan youth, 1997 to 2011. Pediatr Infect Dis J. 2013; 32(11):1289-91 https://doi.org/10.1097/INF.0b013e31829e7d81 PMid:24141802
- Bua A, Molicotti P, Cannas S, Ruggeri M, Olmeo P, Zanetti S. Tuberculin skin test and QuantiFERON in children. New Microbiol. 2013;36 (2):153-6. PMid:23686121
- Molicotti P., Bua A., Mela G., Olmeo P., Ortu S., Sechi L.A., et al. Performance of Quantiferon TB testing in a outbrak at a primary school J. Pediatr. 2008; 152 (4): 585-86 https://doi.org/10.1016/j.jpeds.2007.12.014 PMid:18346520
- Graham SM. Treatment of paediatric TB: revised WHO guidelines. Paediatr Respir Rev. 2011;12 (1):22-6. https://doi.org/10.1016/j.prrv.2010.09.005 PMid:21172671
- Santiago B, Baquero-Artigao F, Mejías A, Blázquez D, Jiménez MS, Mellado-Pe-a MJ; EREMITA Study Group. Pediatric drug-resistant tuberculosis in Madrid: family matters. Pediatr Infect Dis J. 2014;33 (4):345-50. https://doi.org/10.1097/INF.0000000000000111 PMid:24622395
- Pang J, Teeter LD, Katz DJ, Davidow AL, Miranda W, Wall K, et al. Tuberculosis Epidemiologic Studies Consortium. Epidemiology of tuberculosis in young children in the United States. Pediatrics. 2014;133(3):e494-504. https://doi.org/10.1542/peds.2013-2570 PMid:24515517 PMCid:PMC5135007
- Durando P, Sotgiu G, Spigno F, Piccinini M, Mazzarello G, Viscoli C, et al. Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study. BMC Infect Dis. 2013;13:443 https://doi.org/10.1186/1471-2334-13-443 PMid:24059355 PMCid:PMC3848912
- Galli L, Lancella L, Tersigni C, Venturini E, Chiappini E, Bergamini BM, et al. Pediatric Tuberculosis in Italian Children: Epidemiological and Clinical Data from the Italian Register of Pediatric Tuberculosis. Int J Mol Sci. 2016 Jun 17;17(6). pii: E960. doi: 10.3390/ijms17060960. https://doi.org/10.3390/ijms17060960
S, Galli L, Chiappini E, Pinon M, Bergamini BM, Cazzato S, et al.;
SITIP IGRA Study Group. Performance of interferon-? release assay for
the diagnosis of active or latent tuberculosis in children in the first
2 years of age: a multicenter study of the Italian Society of Pediatric
Infectious Diseases. Pediatr Infect Dis J. 2014 Sep;33(9):e226-31. https://doi.org/10.1097/INF.0000000000000353 PMid:25361032
Metrics powered by PLOS ALM
Copyright (c) 2017 Mediterranean Journal of Hematology and Infectious Diseases
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.